Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma
Abstract Many patients with advanced melanoma eventually stop responding to PD-1 immunotherapy, and effective treatments are limited. Recent studies suggest that older chemotherapy drugs such as dacarbazine and temozolomide may work better after prior PD-1 therapy and can stimulate the immune system...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Springer
2026-03-01
|
| Серія: | Discover Oncology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1007/s12672-026-04816-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|